These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 36193307)
1. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer. Misbah M; Kumar M; Lee KH; Shen SC Biomed Res Int; 2022; 2022():3825760. PubMed ID: 36193307 [TBL] [Abstract][Full Text] [Related]
2. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. Lee CC; Lee AW; Wei PL; Liu YS; Chang YJ; Huang CY Sci Rep; 2023 Mar; 13(1):4366. PubMed ID: 36927770 [TBL] [Abstract][Full Text] [Related]
3. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Wang H; Wang X; Zhang H; Deng T; Liu R; Liu Y; Li H; Bai M; Ning T; Wang J; Ge S; Ba Y Oncogene; 2021 Jul; 40(28):4695-4708. PubMed ID: 34140641 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer. Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369 [TBL] [Abstract][Full Text] [Related]
5. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168 [TBL] [Abstract][Full Text] [Related]
6. Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach. Makondi PT; Wei PL; Huang CY; Chang YJ PLoS One; 2019; 14(2):e0211968. PubMed ID: 30807603 [TBL] [Abstract][Full Text] [Related]
7. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411 [TBL] [Abstract][Full Text] [Related]
8. Unveiling the role of miR-137-3p/miR-296-5p/SERPINA3 signaling in colorectal cancer progression: integrative analysis of gene expression profiles and in vitro studies. Liu H; Wu X; Wang D; Li Q; Zhang X; Xu L BMC Med Genomics; 2023 Dec; 16(1):327. PubMed ID: 38087342 [TBL] [Abstract][Full Text] [Related]
9. Identification of key lncRNAs associated with oxaliplatin resistance in colorectal cancer cells and isolated exosomes: From In-Silico prediction to In-Vitro validation. Sahebnasagh R; Deli H; Shadboorestan A; Vakili-Ghartavol Z; Salehi N; Komeili-Movahhed T; Azizi Z; Ghahremani MH PLoS One; 2024; 19(10):e0311680. PubMed ID: 39401197 [TBL] [Abstract][Full Text] [Related]
10. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496 [TBL] [Abstract][Full Text] [Related]
11. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Ghanbarian M; Afgar A; Yadegarazari R; Najafi R; Teimoori-Toolabi L Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807 [TBL] [Abstract][Full Text] [Related]
13. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696 [TBL] [Abstract][Full Text] [Related]
14. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038 [TBL] [Abstract][Full Text] [Related]
16. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer. Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750 [TBL] [Abstract][Full Text] [Related]
17. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333 [TBL] [Abstract][Full Text] [Related]
18. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer. Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680 [TBL] [Abstract][Full Text] [Related]
19. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]